Comparative evaluation of HAS-BLED and ATRIA scores by investigating the full potential of their bleeding prediction schemes in non-valvular atrial fibrillation patients on vitamin-K antagonists

Int J Cardiol. 2014 Oct 20;176(3):1259-61. doi: 10.1016/j.ijcard.2014.07.193. Epub 2014 Aug 7.

Authors

Rami Riziq-Yousef Abumuaileq¹, Emad Abu-Assi², Sergio Raposeiras-Roubin², Andrea López-López², Alfredo Redondo-Diéguez², Diego Álvarez-Iglesias², Moisés Rodríguez-Mañero², Carlos Peña-Gil², Jose Ramón González-Juanatey²

Affiliations

¹ Cardiology Department, Hospital Clínico Universitario de Santiago de Compostela, A Choupana s/n, 15706, Spain. Electronic address: drrami2012@hotmail.com.
² Cardiology Department, Hospital Clínico Universitario de Santiago de Compostela, A Choupana s/n, 15706, Spain.

PMID: 25139324
DOI: 10.1016/j.ijcard.2014.07.193

No abstract available

Keywords: Anticoagulant; Atrial fibrillation; Bleeding; Intracranial hemorrhage; Risk score.

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Anticoagulants / adverse effects*
Anticoagulants / therapeutic use
Atrial Fibrillation / complications*
Female
Global Health
Hemorrhage / chemically induced
Hemorrhage / epidemiology*
Humans
Incidence
Male
Risk Assessment / methods*
Thrombosis / etiology
Thrombosis / prevention & control*
Vitamin K / antagonists & inhibitors*

Substances

Anticoagulants
Vitamin K